{"id":60962,"date":"2026-02-27T12:30:06","date_gmt":"2026-02-27T12:30:06","guid":{"rendered":"https:\/\/www.globalresearch.co.kr\/insight\/pharmaceutical-intermediates-market-mordor\/"},"modified":"2026-09-18T08:16:20","modified_gmt":"2026-09-17T23:16:20","slug":"pharmaceutical-intermediates-market-mordor","status":"publish","type":"post","link":"https:\/\/www.globalresearch.co.kr\/insight\/pharmaceutical-intermediates-market-mordor\/","title":{"rendered":"\uc138\uacc4\uc758 \uc81c\uc57d \uc911\uac04\uccb4 \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc810\uc720\uc728 \ubd84\uc11d &#8211; \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc804\ub9dd (2026-2031)"},"content":{"rendered":"<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pharmaceutical-intermediates-market_1659418506022_CL9.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p><img decoding=\"async\" src=\"https:\/\/www.globalresearch.co.kr\/insight\/wp-content\/uploads\/2026\/02\/pharmaceutical-intermediates-market-size-image-1770824749413.webp\" alt=\"Chart\" class=\"aligncenter size-full\" \/><\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-0\">1. \uc11c\ub860<\/p>\n<ul>\n<li class=\"toc-level-2\">1.1 \uc5f0\uad6c \uac00\uc815 \ubc0f \uc2dc\uc7a5 \uc815\uc758<\/li>\n<li class=\"toc-level-2\">1.2 \uc5f0\uad6c \ubc94\uc704<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-1\">2. \uc5f0\uad6c \ubc29\ubc95\ub860<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-2\">3. \uc694\uc57d<\/p>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-3\">4. \uc2dc\uc7a5 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">4.1 \uc2dc\uc7a5 \uac1c\uc694<\/li>\n<li class=\"toc-level-2\">4.2 \uc2dc\uc7a5 \ub3d9\uc778\n<ul>\n<li class=\"toc-level-3\">4.2.1 \uc544\uc6c3\uc18c\uc2f1 \uc81c\uc870\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654<\/li>\n<li class=\"toc-level-3\">4.2.2 \uc800\ubd84\uc790 \ud56d\uc554\uc81c API \uc218\uc694 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.3 \ubbf8\uad6d \ubc0f \uc720\ub7fd\uc758 \ub9ac\uc1fc\uc5b4\ub9c1 \uc778\uc13c\ud2f0\ube0c<\/li>\n<li class=\"toc-level-3\">4.2.4 \uc5f0\uc18d \ud750\ub984 \ud654\ud559\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00<\/li>\n<li class=\"toc-level-3\">4.2.5 \ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \ubc0f \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc758\uc57d\ud488 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5<\/li>\n<li class=\"toc-level-3\">4.2.6 AI \uae30\ubc18 \uacbd\ub85c \ud0d0\uc0c9 \ubc0f \ud569\uc131 \ucd5c\uc801\ud654<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.3 \uc2dc\uc7a5 \uc81c\uc57d\n<ul>\n<li class=\"toc-level-3\">4.3.1 \uc8fc\uc694 \uc6d0\ub8cc(\uc6a9\ub9e4, \uc2dc\uc57d)\uc758 \ubd88\uc548\uc815\ud55c \uac00\uaca9<\/li>\n<li class=\"toc-level-3\">4.3.2 \uc5c4\uaca9\ud55c \ud658\uacbd \uc601\ud5a5 \uaddc\uc81c \uc900\uc218 \ube44\uc6a9<\/li>\n<li class=\"toc-level-3\">4.3.3 \uc774\uc911 \uc6a9\ub3c4 \uc804\uad6c\uccb4\uc5d0 \ub300\ud55c \uc9c0\uc815\ud559\uc801 \uc218\ucd9c \ud1b5\uc81c<\/li>\n<li class=\"toc-level-3\">4.3.4 \uace0\ud6a8\ub2a5 \uc911\uac04\uccb4\uc5d0 \ub300\ud55c CDMO \uc0dd\uc0b0 \ub2a5\ub825 \ubcd1\ubaa9 \ud604\uc0c1<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">4.4 \uac00\uce58 \/ \uacf5\uae09\ub9dd \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">4.5 \uaddc\uc81c \ud658\uacbd<\/li>\n<li class=\"toc-level-2\">4.6 \uae30\uc220 \uc804\ub9dd<\/li>\n<li class=\"toc-level-2\">4.7 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778\n<ul>\n<li class=\"toc-level-3\">4.7.1 \uc2e0\uaddc \uc9c4\uc785\uc790\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.2 \uacf5\uae09\uc5c5\uccb4\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.3 \uad6c\ub9e4\uc790\uc758 \uad50\uc12d\ub825<\/li>\n<li class=\"toc-level-3\">4.7.4 \ub300\uccb4\uc7ac\uc758 \uc704\ud611<\/li>\n<li class=\"toc-level-3\">4.7.5 \uacbd\uc7c1 \uac15\ub3c4<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-4\">5. \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21 (\uac00\uce58, USD \uc2ed\uc5b5)<\/p>\n<ul>\n<li class=\"toc-level-2\">5.1 \uc81c\ud488 \uc720\ud615\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.1.1 \uc6d0\ub8cc\uc758\uc57d\ud488 \uc911\uac04\uccb4<\/li>\n<li class=\"toc-level-3\">5.1.2 \ub9de\ucda4\ud615 &amp; \uacc4\uc57d \uc911\uac04\uccb4<\/li>\n<li class=\"toc-level-3\">5.1.3 \ud3a9\ud0c0\uc774\ub4dc &amp; \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc911\uac04\uccb4<\/li>\n<li class=\"toc-level-3\">5.1.4 \ud0a4\ub784 &amp; \uace0\ud6a8\ub2a5 \uc911\uac04\uccb4<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.2 \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.2.1 \uc885\uc591\ud559<\/li>\n<li class=\"toc-level-3\">5.2.2 \uc2ec\ud608\uad00<\/li>\n<li class=\"toc-level-3\">5.2.3 \uac10\uc5fc\ubcd1<\/li>\n<li class=\"toc-level-3\">5.2.4 \uc911\ucd94\uc2e0\uacbd\uacc4<\/li>\n<li class=\"toc-level-3\">5.2.5 \ub300\uc0ac &amp; \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.3 \ud569\uc131 \uacf5\uc815\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.3.1 \uc804\ud1b5\uc801\uc778 \ubc30\uce58 \ud654\ud559<\/li>\n<li class=\"toc-level-3\">5.3.2 \uc5f0\uc18d \ud750\ub984 \ud654\ud559<\/li>\n<li class=\"toc-level-3\">5.3.3 \uc0dd\uccb4 \ucd09\ub9e4 &amp; \ud6a8\uc18c \uacbd\ub85c<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.4 \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.4.1 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \uc81c\uc870\uc5c5\uccb4<\/li>\n<li class=\"toc-level-3\">5.4.2 \ud601\uc2e0 \uc81c\uc57d \ud68c\uc0ac<\/li>\n<li class=\"toc-level-3\">5.4.3 \uacc4\uc57d \uc5f0\uad6c &amp; \uc81c\uc870 \uc870\uc9c1 (CRO\/CDMO)<\/li>\n<\/ul>\n<\/li>\n<li class=\"toc-level-2\">5.5 \uc9c0\uc5ed\ubcc4\n<ul>\n<li class=\"toc-level-3\">5.5.1 \ubd81\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.1.1 \ubbf8\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.1.2 \uce90\ub098\ub2e4<\/li>\n<li class=\"toc-level-4\">5.5.1.3 \uba55\uc2dc\ucf54<\/li>\n<li class=\"toc-level-3\">5.5.2 \uc720\ub7fd<\/li>\n<li class=\"toc-level-4\">5.5.2.1 \ub3c5\uc77c<\/li>\n<li class=\"toc-level-4\">5.5.2.2 \uc601\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.2.3 \ud504\ub791\uc2a4<\/li>\n<li class=\"toc-level-4\">5.5.2.4 \uc774\ud0c8\ub9ac\uc544<\/li>\n<li class=\"toc-level-4\">5.5.2.5 \uc2a4\ud398\uc778<\/li>\n<li class=\"toc-level-4\">5.5.2.6 \uc720\ub7fd \uae30\ud0c0<\/li>\n<li class=\"toc-level-3\">5.5.3 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<\/li>\n<li class=\"toc-level-4\">5.5.3.1 \uc911\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.2 \uc778\ub3c4<\/li>\n<li class=\"toc-level-4\">5.5.3.3 \uc77c\ubcf8<\/li>\n<li class=\"toc-level-4\">5.5.3.4 \ub300\ud55c\ubbfc\uad6d<\/li>\n<li class=\"toc-level-4\">5.5.3.5 \ud638\uc8fc<\/li>\n<li class=\"toc-level-4\">5.5.3.6 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uae30\ud0c0<\/li>\n<li class=\"toc-level-3\">5.5.4 \ub0a8\ubbf8<\/li>\n<li class=\"toc-level-4\">5.5.4.1 \ube0c\ub77c\uc9c8<\/li>\n<li class=\"toc-level-4\">5.5.4.2 \uc544\ub974\ud5e8\ud2f0\ub098<\/li>\n<li class=\"toc-level-4\">5.5.4.3 \ub0a8\ubbf8 \uae30\ud0c0<\/li>\n<li class=\"toc-level-3\">5.5.5 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.5.1 GCC<\/li>\n<li class=\"toc-level-4\">5.5.5.2 \ub0a8\uc544\ud504\ub9ac\uce74<\/li>\n<li class=\"toc-level-4\">5.5.5.3 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uae30\ud0c0<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-5\">6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<ul>\n<li class=\"toc-level-2\">6.1 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4<\/li>\n<li class=\"toc-level-2\">6.2 \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d<\/li>\n<li class=\"toc-level-2\">6.3 \uae30\uc5c5 \ud504\ub85c\ud544 (\uae00\ub85c\ubc8c \uac1c\uc694, \uc2dc\uc7a5 \uac1c\uc694, \ud575\uc2ec \ubd80\ubb38, \uc7ac\ubb34 \uc815\ubcf4(\uc0ac\uc6a9 \uac00\ub2a5\ud55c \uacbd\uc6b0), \uc804\ub7b5 \uc815\ubcf4, \uc2dc\uc7a5 \uc21c\uc704\/\uc810\uc720\uc728, \uc81c\ud488 &amp; \uc11c\ube44\uc2a4, \ucd5c\uadfc \uac1c\ubc1c \ud3ec\ud568)\n<ul>\n<li class=\"toc-level-3\">6.3.1 \ub860\uc790 \uadf8\ub8f9 AG<\/li>\n<li class=\"toc-level-3\">6.3.2 \uc6b0\uc2dc \uc571\ud14d Co., Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.3 \uc368\ubaa8 \ud53c\uc154 \uc0ac\uc774\uc5b8\ud2f0\ud53d Inc.<\/li>\n<li class=\"toc-level-3\">6.3.4 \ucea0\ube0c\ub809\uc2a4 \ucf54\ud37c\ub808\uc774\uc158<\/li>\n<li class=\"toc-level-3\">6.3.5 \uc9c0\uadf8\ud504\ub9ac\ub4dc \ud640\ub529 AG<\/li>\n<li class=\"toc-level-3\">6.3.6 \ub514\ube44\uc2a4 \ub798\ubc84\ub7ec\ud1a0\ub9ac\uc2a4 Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.7 \uc544\ub974\ud2f0 \uc778\ub354\uc2a4\ud2b8\ub9ac\uc988 Limited<\/li>\n<li class=\"toc-level-3\">6.3.8 \ud050\ub9ac\uc544 \uae00\ub85c\ubc8c, Inc.<\/li>\n<li class=\"toc-level-3\">6.3.9 \ub514\uc26c\ub9cc \uce74\ubcf4\uc820 \uc554\uc2dc\uc2a4 Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.10 \uc8fc\ube4c\ub780\ud2b8 \ud30c\ubaa8\ubc14 Limited<\/li>\n<li class=\"toc-level-3\">6.3.11 \uc0ac\ub178\ud53c S.A.<\/li>\n<li class=\"toc-level-3\">6.3.12 \uba38\ud06c KGaA<\/li>\n<li class=\"toc-level-3\">6.3.13 \ubc14\uc2a4\ud504 SE<\/li>\n<li class=\"toc-level-3\">6.3.14 \ud5e4\ud14c\ub85c \ub7a9\uc2a4 Limited<\/li>\n<li class=\"toc-level-3\">6.3.15 \ud654\uc774\uc790 Inc.<\/li>\n<li class=\"toc-level-3\">6.3.16 \uc544\uc2ec\ucf10 \ub798\ubc84\ub7ec\ud1a0\ub9ac\uc2a4<\/li>\n<li class=\"toc-level-3\">6.3.17 \ud3ec\ub974\ud1a4 \ud30c\ub9c8 \uc194\ub8e8\uc158\uc988 Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.18 \uc54c\ub9e5 \uadf8\ub8f9 Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.19 \ub77d\uc2a4\ubbf8 \uc624\uac00\ub2c9 \uc778\ub354\uc2a4\ud2b8\ub9ac\uc988 Ltd.<\/li>\n<li class=\"toc-level-3\">6.3.20 \uc5d0\uc2a4\ud14c\ubca0 \ud0a4\ubbf8\uce74<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p class=\"toc-level-1 toc-content-heading\" id=\"toc-content-heading-6\">7. \uc2dc\uc7a5 \uae30\ud68c &amp; \ubbf8\ub798 \uc804\ub9dd<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5 \uac1c\uc694: \uc131\uc7a5 \ub3d9\ud5a5 \ubc0f \uc608\uce21 (2026-2031)<\/p>\n<p># 1. \uc2dc\uc7a5 \uac1c\uc694 \ubc0f \uc8fc\uc694 \uc218\uce58<\/p>\n<p>\uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc740 2025\ub144 454\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\ub85c \ud3c9\uac00\ub418\uc5c8\uc73c\uba70, 2026\ub144 486\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0\uc11c 2031\ub144 683\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc608\uce21 \uae30\uac04(2026-2031) \ub3d9\uc548 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.05%\ub97c \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc131\uc7a5\uc740 \uc758\uc57d\ud488 \uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0(CDMO) \uc120\ud638\ub3c4 \uc99d\uac00, \uc5f0\uc18d \ud750\ub984 \ud654\ud559(continuous-flow chemistry)\uc758 \ubd80\ud65c, \ud575\uc2ec \uc6d0\ub8cc \uad6d\ub0b4 \ubcf5\uadc0\ub97c \uc704\ud55c \uc815\ubd80 \uc778\uc13c\ud2f0\ube0c, \ud56d\uc554\uc81c \ubc0f \ud3a9\ud0c0\uc774\ub4dc \uc758\uc57d\ud488 \ud30c\uc774\ud504\ub77c\uc778 \ud655\ub300 \ub4f1\uc5d0 \uc758\ud574 \uc8fc\ub3c4\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub610\ud55c, AI \uae30\ubc18 \uacbd\ub85c \ud0d0\uc0c9\uacfc \uac19\uc740 \ud601\uc2e0 \uae30\uc220 \ubc0f \ubbf8\uad6d FDA\uc758 \ucca8\ub2e8 \uc81c\uc870 \uae30\uc220 \uc774\ub2c8\uc154\ud2f0\ube0c\uc640 \uac19\uc740 \uaddc\uc81c \ud504\ub85c\uadf8\ub7a8\uc740 \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uac00\uc18d\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc774\ub7ec\ud55c \uc694\uc778\ub4e4\uc740 \uc18d\ub3c4, \uc720\uc5f0\uc131, \ud488\uc9c8\uc774 \ud575\uc2ec \uacbd\uc7c1 \uc694\uc18c\uac00 \ub41c \uc0dd\ud0dc\uacc4\uc5d0\uc11c \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc758 \uc911\ucd94\uc801\uc778 \uc5ed\ud560\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \uc218\uce58 (2026-2031 \uc608\uce21):<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8 (2026): 486\uc5b5 5\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc2dc\uc7a5 \uaddc\ubaa8 (2031): 683\uc5b5 7\ucc9c\ub9cc \ub2ec\ub7ec<br \/>\n*   \uc131\uc7a5\ub960 (2026-2031): 7.05% CAGR<br \/>\n*   \uac00\uc7a5 \ube60\ub974\uac8c \uc131\uc7a5\ud558\ub294 \uc2dc\uc7a5: \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591<br \/>\n*   \uac00\uc7a5 \ud070 \uc2dc\uc7a5: \ubd81\ubbf8<br \/>\n*   \uc2dc\uc7a5 \uc9d1\uc911\ub3c4: \uc911\uac04<\/p>\n<p># 2. \uc8fc\uc694 \ubcf4\uace0\uc11c \uc694\uc57d<\/p>\n<p>*   \uc81c\ud488 \uc720\ud615\ubcc4: \ubc8c\ud06c \uc758\uc57d\ud488 \uc911\uac04\uccb4(Bulk Drug Intermediates)\uac00 2024\ub144 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 48.67%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ud3a9\ud0c0\uc774\ub4dc \ubc0f \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc911\uac04\uccb4(Peptide &#038; Oligonucleotide Intermediates)\ub294 2030\ub144\uae4c\uc9c0 8.12%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c\ubcc4: \ud56d\uc554\uc81c(Oncology) \ubd84\uc57c\uac00 2024\ub144 \ub9e4\ucd9c \uc810\uc720\uc728 37.67%\ub85c \uc120\ub450\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 2025-2030\ub144 \ub3d9\uc548 7.68%\uc758 \uac00\uc7a5 \ub192\uc740 CAGR\uc744 \uc720\uc9c0\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<br \/>\n*   \ud569\uc131 \uacf5\uc815\ubcc4: \uc804\ud1b5\uc801\uc778 \ubc30\uce58 \ud654\ud559(Traditional Batch Chemistry)\uc774 2024\ub144 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5 \uaddc\ubaa8\uc758 69.67%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \uc5f0\uc18d \ud750\ub984 \ud654\ud559(Continuous-Flow Chemistry)\uc740 \uc608\uce21 \uae30\uac04 \ub3d9\uc548 8.10%\uc758 CAGR\ub85c \ud655\uc7a5\ub420 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4: \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \uc81c\uc870\uc5c5\uccb4(Generic Drug Manufacturers)\uac00 2024\ub144 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 53.82%\ub97c \ucc28\uc9c0\ud588\uc9c0\ub9cc, \ud601\uc2e0 \uc81c\uc57d \ud68c\uc0ac(Innovative Pharma Companies)\ub294 2030\ub144\uae4c\uc9c0 7.98%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4.<br \/>\n*   \uc9c0\uc5ed\ubcc4: \ubd81\ubbf8\uac00 2024\ub144 \uc804 \uc138\uacc4 \uac00\uce58\uc758 42.23%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \ud5a5\ud6c4 5\ub144\uac04 8.34%\uc758 \uac00\uc7a5 \ube60\ub978 CAGR\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p># 3. \uae00\ub85c\ubc8c \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5 \ub3d9\ud5a5 \ubc0f \ud1b5\ucc30\ub825<\/p>\n<p>3.1. \uc2dc\uc7a5 \uc131\uc7a5 \ub3d9\uc778<\/p>\n<p>*   \uc758\uc57d\ud488 \uc704\ud0c1\uc0dd\uc0b0(Outsourced Manufacturing)\uc73c\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654: \uc2e0\uc57d \uac1c\ubc1c\uc0ac\ub4e4\uc774 \uc790\ubcf8 \ud6a8\uc728\uc801\uc778 \ubaa8\ub378\uacfc \uacf5\uae09\ub9dd \uc704\ud5d8 \ubd84\uc0b0\uc744 \ucd94\uad6c\ud568\uc5d0 \ub530\ub77c \uc704\ud0c1 \uc11c\ube44\uc2a4\uac00 \uc2e0\uaddc \ud654\ud559 \ubb3c\uc9c8 \uc0dd\uc0b0\uc758 \ud575\uc2ec\uc73c\ub85c \uc790\ub9ac \uc7a1\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud480\uc11c\ube44\uc2a4 CDMO\ub294 \uc790\uccb4 \uac1c\ubc1c \ub300\ube44 25%\uc758 \ube44\uc6a9 \uc808\uac10\uacfc 50%\uc758 \uac1c\ubc1c \uae30\uac04 \ub2e8\ucd95\uc744 \uc81c\uacf5\ud55c\ub2e4\uace0 \ud64d\ubcf4\ud569\ub2c8\ub2e4. 2025\ub144 \uc124\ubb38\uc870\uc0ac\uc5d0 \ub530\ub974\uba74, \uacbd\uc601\uc9c4\uc758 81%\uac00 \ucd5c\uc18c\ud55c \ud558\ub098\uc758 \uc81c\uc870 \ub2e8\uacc4\ub97c \ub3d9\uc77c \uacbd\uc81c\uad8c \ub0b4 CDMO\ub85c \uc774\uc804\ud560 \uacc4\ud68d\uc744 \uc138\uc6b0\ub294 \ub4f1 \ud32c\ub370\ubbf9 \uc774\ud6c4 \ud575\uc2ec \uc911\uac04\uccb4\uc758 \ud604\uc9c0\ud654 \uacbd\ud5a5\uc774 \uac15\ud574\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4. FDA \ucca8\ub2e8 \uc81c\uc870 \uae30\uc220 \uc9c0\uc815 \ud504\ub85c\uadf8\ub7a8\uacfc \uac19\uc740 \uaddc\uc81c \uc2b9\uc778\uc740 \uc778\uc99d\ub41c \uc2dc\uc124\uc5d0 \ub354 \ube60\ub978 \uc0ac\uc804 \uc2b9\uc778 \uac80\uc0ac \ubc0f \uc2ec\uc0ac \uae30\uac04 \ub2e8\ucd95 \ud61c\ud0dd\uc744 \uc81c\uacf5\ud558\uc5ec \uc544\uc6c3\uc18c\uc2f1\uc744 \ub354\uc6b1 \uc7a5\ub824\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc18c\ubd84\uc790 \ud56d\uc554\uc81c API \uc218\uc694 \uc99d\uac00: 2024\ub144 \uc804 \uc138\uacc4\uc801\uc73c\ub85c 25\uac1c\uc758 \uc0c8\ub85c\uc6b4 \ud56d\uc554 \ud65c\uc131 \ubb3c\uc9c8\uc774 \ucd9c\uc2dc\ub418\uc5b4 5\ub144\uac04\uc758 \uc2e0\uaddc \ucd9c\uc2dc \uac74\uc218\uac00 132\uac1c\ub85c \uc99d\uac00\ud588\uc73c\uba70, \uc774\ub294 \ud2b9\uc218 \uc911\uac04\uccb4 \uc8fc\ubb38\uc758 \uae09\uc99d\uc744 \uc57c\uae30\ud588\uc2b5\ub2c8\ub2e4. 2019\ub144 \uc774\ud6c4 \ud56d\uc554\uc81c \ud30c\uc774\ud504\ub77c\uc778\uc758 \uc0dd\uc0b0\uc131\uc740 51% \ud5a5\uc0c1\ub418\uc5c8\uc9c0\ub9cc, \uae30\uc800 \ud654\ud559\uc740 \ub354\uc6b1 \ubcf5\uc7a1\ud574\uc838 \ub2e4\ub2e8\uacc4 \uace0\uc5ed\uac00 \ucc98\ub9ac \ubc0f \ub9de\ucda4\ud615 \ud0a4\ub784 \ucd09\ub9e4\ub97c \uc694\uad6c\ud558\ub294 \uacbd\uc6b0\uac00 \ub9ce\uc2b5\ub2c8\ub2e4. \ubd81\ubbf8 \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc774 \uc815\ubc00 \uc758\ud559 \uc784\uc0c1 \uc2dc\ud5d8\uc744 \uc8fc\ub3c4\ud558\uace0 \uc788\uc9c0\ub9cc, \uc911\uad6d CDMO\ub4e4\uc774 2\uc138\ub300 \ud2f0\ub85c\uc2e0 \ud0a4\ub098\uc544\uc81c \uc5b5\uc81c\uc81c \uc2dc\uc7a5\uc5d0\uc11c \uc810\uc720\uc728\uc744 \ud655\ubcf4\ud558\uba74\uc11c \uae00\ub85c\ubc8c \uc18c\uc2f1 \ud328\ud134\uc774 \ubcf5\uc7a1\ud574\uc9c0\uace0 \uc774\uc911 \uc9c0\uc5ed \uacf5\uae09 \uc804\ub7b5\uc758 \ud544\uc694\uc131\uc774 \ucee4\uc9c0\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \ubbf8\uad6d \ubc0f \uc720\ub7fd\uc758 \ub9ac\uc1fc\uc5b4\ub9c1 \uc778\uc13c\ud2f0\ube0c: 2025\ub144 \ubbf8\uad6d \uc81c\uc870\uc5c5\uccb4\ub4e4\uc740 \uc138\uae08 \uacf5\uc81c, FDA PreCheck \ud30c\uc77c\ub7ff \ud504\ub85c\uadf8\ub7a8, \ud544\uc218 \uc758\uc57d\ud488 API\uc5d0 \ub300\ud55c \uc5f0\ubc29 \ubcf4\uc870\uae08\uc5d0 \ud798\uc785\uc5b4 \uad6d\ub0b4 \uc81c\uc57d \uc2dc\uc124\uc5d0 1,600\uc5b5 \ub2ec\ub7ec\ub97c \ud22c\uc790\ud588\uc2b5\ub2c8\ub2e4. \ud504\ub791\uc2a4\uc640 \uc624\uc2a4\ud2b8\ub9ac\uc544\uc758 \uc720\uc0ac\ud55c \ud328\ud0a4\uc9c0\ub294 \uc5f0\uc18d \uc0dd\uc0b0 \ub77c\uc778\uc744 \uc0ac\uc6a9\ud558\ub294 \ud604\uc9c0 API \ub2e8\uc9c0\uc5d0 \ubcf4\uc870\uae08\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uadf8 \uacb0\uacfc, \uc774\ub4e4 \uc9c0\uc5ed\uc758 \uc911\uac04\uccb4 \uc0dd\uc0b0\ub7c9\uc740 \uc644\uc81c \uc758\uc57d\ud488 \uc131\uc7a5\ub960\ubcf4\ub2e4 \ube60\ub974\uac8c \uc99d\uac00\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub418\uba70, \uc774\ub294 \ud604\uc9c0 \uc6d0\ub8cc \uc2dc\uc7a5\uc744 \uc555\ubc15\ud558\uace0 Novo Holdings\uc758 Catalent \uc778\uc218\uc640 \uac19\uc740 \uc218\uc9c1 \ud1b5\ud569 \uc6c0\uc9c1\uc784\uc744 \ucd09\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc5f0\uc18d \ud750\ub984 \ud654\ud559\uc5d0 \ub300\ud55c \ud22c\uc790 \uc99d\uac00: \uc5f0\uc18d \ud750\ub984 \ubc18\uc751\uae30\ub294 \uc2dc\uc124 \uba74\uc801\uc744 \ucd5c\ub300 70%\uae4c\uc9c0 \uc904\uc774\uace0 \ubcc0\ub3d9 \ube44\uc6a9\uc744 40-50% \uc808\uac10\ud558\uc5ec \ud55c\ub54c \uc544\uc2dc\uc544 \uc704\ud0c1 \uc0dd\uc0b0 \uc5c5\uccb4\uac00 \uc9c0\ubc30\ud588\ub358 \ubd80\ubb38\uc5d0\uc11c \uc11c\uad6c\uad8c\uc758 \uacbd\uc81c\uc131\uc744 \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4. \ucd08\uae30 \ub3c4\uc785 \uae30\uc5c5\ub4e4\uc740 \uc804\ud1b5\uc801\uc778 \ubc30\uce58 \ubc29\uc2dd\ubcf4\ub2e4 \uc9e7\uc740 FDA \uc2b9\uc778 \uae30\uac04\uc744 \ubcf4\uace0\ud588\uc73c\uba70, ICH Q13\uc740 \uae00\ub85c\ubc8c \uac80\uc99d\uc744 \uc704\ud55c \uc870\ud654\ub41c \uacbd\ub85c\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4. \ub300\ud615 \uc81c\uc57d\uc0ac\ub4e4\uc740 \uae30\uc874 \ub77c\uc778\uc744 \uac1c\uc870\ud558\uace0 \uc788\uc73c\uba70, \uc778\ub3c4, \uc2f1\uac00\ud3ec\ub974, \uc544\uc77c\ub79c\ub4dc\uc758 \uc2e0\uaddc \uacf5\uc7a5\uc740 \ud750\ub984 \uc6b0\uc120(flow-first)\uc73c\ub85c \uc124\uacc4\ub418\uc5b4 \uc774 \uae30\uc220\uc758 \ube60\ub978 \uc2dc\uc7a5 \uc810\uc720\uc728 \ud655\ub300\ub97c \uac00\ub2a5\ud558\uac8c \ud569\ub2c8\ub2e4.<br \/>\n*   \ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \ubc0f \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc758\uc57d\ud488 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5: \uc0dd\ubb3c\ud559\uc801 \uc81c\uc81c\uc640 \uc720\uc0ac\ud55c \ud654\ud559 \ubb3c\uc9c8\uc758 \uc784\uc0c1\uc801 \ubaa8\uba58\ud140\uc774 \uc99d\uac00\ud558\uba74\uc11c \uad00\ub828 \uc911\uac04\uccb4 \uc218\uc694\uac00 \uc99d\uac00\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   AI \uae30\ubc18 \uacbd\ub85c \ud0d0\uc0c9 \ubc0f \ud569\uc131 \ucd5c\uc801\ud654: AI \uae30\ubc18 \uacbd\ub85c \ud0d0\uc0c9 \ubc0f \ud569\uc131 \ucd5c\uc801\ud654 \uae30\uc220\uc740 \uac1c\ubc1c \uc77c\uc815\uc744 \ub2e8\ucd95\ud558\uace0 \ud6a8\uc728\uc131\uc744 \ub192\uc5ec \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>3.2. \uc2dc\uc7a5 \uc131\uc7a5 \uc81c\uc57d \uc694\uc778<\/p>\n<p>*   \ud575\uc2ec \uc6d0\ub8cc(\uc6a9\ub9e4, \uc2dc\uc57d) \uac00\uaca9 \ubcc0\ub3d9\uc131: \uc6d0\ub8cc \uac00\uaca9\uc758 \ubd88\uc548\uc815\uc131\uc740 \ud2b9\ud788 \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc5d0\uc11c \ub2e8\uae30\uc801\uc73c\ub85c \uc2dc\uc7a5 \uc131\uc7a5\uc5d0 \ubd80\uc815\uc801\uc778 \uc601\ud5a5\uc744 \ubbf8\uce69\ub2c8\ub2e4.<br \/>\n*   \uc5c4\uaca9\ud55c \ud658\uacbd \uc601\ud5a5 \uaddc\uc81c \uc900\uc218 \ube44\uc6a9: \uc720\ub7fd\uacfc \ubd81\ubbf8\ub97c \uc911\uc2ec\uc73c\ub85c \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud658\uacbd \uaddc\uc81c \uc900\uc218 \ube44\uc6a9\uc774 \uc99d\uac00\ud558\uba74\uc11c \uc911\uac04\uccb4 \uc0dd\uc0b0 \uae30\uc5c5\uc5d0 \ubd80\ub2f4\uc73c\ub85c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<br \/>\n*   \uc774\uc911 \uc6a9\ub3c4 \uc804\uad6c\uccb4\uc5d0 \ub300\ud55c \uc9c0\uc815\ud559\uc801 \uc218\ucd9c \ud1b5\uc81c: \ubbf8\uad6d-\uc911\uad6d \ubb34\uc5ed \ud68c\ub791\uc744 \uc911\uc2ec\uc73c\ub85c \uc804 \uc138\uacc4\uc801\uc73c\ub85c \ud655\ub300\ub418\ub294 \uc774\uc911 \uc6a9\ub3c4 \uc804\uad6c\uccb4\uc5d0 \ub300\ud55c \uc218\ucd9c \ud1b5\uc81c\ub294 \uacf5\uae09\ub9dd\uc5d0 \ubd88\ud655\uc2e4\uc131\uc744 \ub354\ud569\ub2c8\ub2e4.<br \/>\n*   \uace0\uc5ed\uac00 \uc911\uac04\uccb4\uc5d0 \ub300\ud55c CDMO \uc0dd\uc0b0 \ub2a5\ub825 \ubcd1\ubaa9 \ud604\uc0c1: \uace0\uc5ed\uac00 \uc911\uac04\uccb4 \uc0dd\uc0b0\uc744 \uc704\ud55c CDMO\uc758 \uc81c\ud55c\ub41c \uc0dd\uc0b0 \ub2a5\ub825\uc740 \ud2b9\ud788 \ubd81\ubbf8\uc640 \uc720\ub7fd\uc5d0\uc11c \ub2e8\uae30\uc801\uc778 \uc81c\uc57d \uc694\uc778\uc73c\ub85c \uc791\uc6a9\ud569\ub2c8\ub2e4.<\/p>\n<p># 4. \uc138\uadf8\uba3c\ud2b8 \ubd84\uc11d<\/p>\n<p>4.1. \uc81c\ud488 \uc720\ud615\ubcc4 \ubd84\uc11d: \ubcf5\ud569 \uc911\uac04\uccb4\uac00 \ud601\uc2e0\uc744 \uc8fc\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n2025\ub144 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc5d0\uc11c \ubc8c\ud06c \uc758\uc57d\ud488 \uc911\uac04\uccb4(Bulk Drug Intermediates)\uac00 48.10%\uc758 \uc810\uc720\uc728\ub85c \uc120\ub450\ub97c \uc720\uc9c0\ud588\uc73c\uba70, \uc774\ub294 \ub300\ub7c9 \uc0dd\uc0b0\ub418\ub294 \uc18c\ubd84\uc790 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \ubc0f \uae30\uc874 \uce58\ub8cc\uc81c\uc5d0 \uc758\ud574 \ub4b7\ubc1b\uce68\ub429\ub2c8\ub2e4. \ud3a9\ud0c0\uc774\ub4dc \ubc0f \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc911\uac04\uccb4(Peptide &#038; Oligonucleotide Intermediates)\ub294 \uc808\ub300\uc801\uc778 \uac00\uce58\ub294 \uc791\uc9c0\ub9cc, \uc0dd\ubb3c\ud559\uc801 \uc720\uc0ac \ud654\ud559 \ubb3c\uc9c8\uc774 \uc784\uc0c1\uc801 \ubaa8\uba58\ud140\uc744 \uc5bb\uc73c\uba74\uc11c 7.85%\uc758 \uac00\uc7a5 \ube60\ub978 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ub9de\ucda4\ud615 \ubc0f \uacc4\uc57d \uc911\uac04\uccb4(Custom &#038; Contract Intermediates)\ub294 \ud601\uc2e0 \uae30\uc5c5\ub4e4\uc774 \uc2e0\uc18d\ud55c \uc2b9\uc778 \uc77c\uc815\uc744 \ucda9\uc871\ud558\ub294 \ud134\ud0a4 \ud569\uc131(turnkey synthesis)\uc744 \uc120\ud638\ud568\uc5d0 \ub530\ub77c \uc9c0\uc18d\uc801\uc73c\ub85c \uc131\uc7a5\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud0a4\ub784 \ubc0f \uace0\uc5ed\uac00 \uc911\uac04\uccb4(Chiral &#038; High-potency Intermediates) \uc2dc\uc7a5\uc740 \uc815\ubc00\ud55c \uc785\uccb4\ud654\ud559 \ubc0f \ud2b9\uc218 \ubd09\uc1c4\ub97c \uc694\uad6c\ud558\ub294 \ud56d\uc554\uc81c \ud30c\uc774\ud504\ub77c\uc778\uc5d0 \ud798\uc785\uc5b4 \uafb8\uc900\ud788 \ud655\ub300\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud750\ub984 \ud654\ud559\uacfc \ucca8\ub2e8 \uc720\ud574 \ubb3c\uc9c8 \uad00\ub9ac\ub97c \uacb0\ud569\ud560 \uc218 \uc788\ub294 CDMO\ub294 \ub2e4\ub144\uac04\uc758 \ub9c8\uc2a4\ud130 \uc11c\ube44\uc2a4 \uacc4\uc57d\uc744 \uccb4\uacb0\ud558\uba70, \ud504\ub9ac\ubbf8\uc5c4, \uc18c\ub7c9, \uace0\ub9c8\uc9c4 \ud558\uc704 \ubd80\ubb38\uc73c\ub85c\uc758 \uad6c\uc870\uc801 \uc804\ud658\uc744 \ubcf4\uc5ec\uc90d\ub2c8\ub2e4.<\/p>\n<p>4.2. \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c\ubcc4 \ubd84\uc11d: \ud56d\uc554\uc81c\uac00 \uc131\uc7a5\uc744 \uc8fc\ub3c4\ud569\ub2c8\ub2e4.<br \/>\n2025\ub144 \ud56d\uc554\uc81c(Oncology) \ubd84\uc57c\ub294 37.20%\uc758 \ub9e4\ucd9c\uc744 \uae30\ub85d\ud588\uc73c\uba70, 7.35%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uc720\uc9c0\ud558\uba70 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \uac00\uce58 \ub3d9\uc778\uc73c\ub85c\uc11c\uc758 \uc704\uc0c1\uc744 \uac15\ud654\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uba74\uc5ed \ud56d\uc554\uc81c \ubcf5\ud569\uccb4 \ubc0f \ud56d\uccb4-\uc57d\ubb3c \uc811\ud569\uccb4(ADC)\ub294 \ubcf5\uc7a1\ud55c \ub9c1\ucee4 \ud654\ud559\uc744 \ud544\uc694\ub85c \ud558\uc5ec \ucd08\uace0\uc21c\ub3c4 \uc911\uac04\uccb4 \uc218\uc694\ub97c \uc99d\uac00\uc2dc\ud0b5\ub2c8\ub2e4. \uc2ec\ud608\uad00 \uc9c8\ud658 \uce58\ub8cc\uc81c(Cardiovascular Agents)\ub294 \uc5ec\ub7ec \ud2b9\ud5c8 \ub9cc\ub8cc \ud6c4 \uc644\ud654\ub418\uace0 \uc788\uc9c0\ub9cc, \ub9cc\uc131 \uc9c8\ud658 \uc720\ubcd1\ub960\uc744 \uace0\ub824\ud560 \ub54c \uc0c1\ub2f9\ud55c \uae30\ubcf8 \uc911\uac04\uccb4\ub97c \uacc4\uc18d \uc694\uad6c\ud569\ub2c8\ub2e4. AI\ub85c \ubc1c\uacac\ub41c \ubd84\uc790\ub4e4\uc774 \uc784\uc0c1 \uc2dc\ud5d8\uc5d0 \uc9c4\uc785\ud558\uba74\uc11c \uc911\ucd94\uc2e0\uacbd\uacc4(CNS) \ud6c4\ubcf4 \ubb3c\uc9c8\uc774 \ub2e4\uc2dc \ubd80\uc0c1\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \ud2b9\uc218 \uc544\ubbf8\ub4dc \ubc0f \ud5e4\ud14c\ub85c\uc0ac\uc774\ud074 \uc911\uac04\uccb4 \uc18c\ube44\ub97c \uac00\uc18d\ud654\ud560 \uac83\uc73c\ub85c \ubcf4\uc785\ub2c8\ub2e4. \uac10\uc5fc\ubcd1(Infectious Disease) \ud504\ub85c\uadf8\ub7a8\uc740 \uc815\ubd80\uac00 \ud56d\ubc14\uc774\ub7ec\uc2a4\uc81c \ubc0f \ubc31\uc2e0\uc744 \ube44\ucd95\ud568\uc5d0 \ub530\ub77c \uc804\ub7b5\uc801\uc73c\ub85c \uc911\uc694\ud558\uba70, \uc911\uac04 \uaddc\ubaa8\uc758 \uc218\uc694\ub97c \uc720\uc9c0\ud569\ub2c8\ub2e4. \ub300\uc0ac \uc9c8\ud658(Metabolic Disorders), \ud2b9\ud788 \ube44\ub9cc\uc740 GLP-1 \uc791\uc6a9\uc81c\uc640 \uad00\ub828\ub41c \ud3a9\ud0c0\uc774\ub4dc \uc911\uac04\uccb4 \uc8fc\ubb38\uc744 \uc790\uadf9\ud569\ub2c8\ub2e4.<\/p>\n<p>4.3. \ud569\uc131 \uacf5\uc815\ubcc4 \ubd84\uc11d: \uc804\ud1b5\uc801\uc778 \ubc29\ubc95\uc774 \ub514\uc9c0\ud138 \ud601\uc2e0\uc5d0 \uc9c1\uba74\ud569\ub2c8\ub2e4.<br \/>\n\uae30\uc874 \ubc30\uce58 \ud654\ud559(Traditional Batch Chemistry)\uc740 \ud655\uace0\ud55c \uac80\uc99d \ud30c\uc77c\uacfc \uac10\uac00\uc0c1\uac01\ub41c \uc790\uc0b0\uc73c\ub85c \uc778\ud574 \uc5ec\uc804\ud788 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc758 69.05%\ub97c \ucc28\uc9c0\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \uc5f0\uc18d \ud750\ub984 \ud654\ud559(Continuous-Flow Chemistry)\uc740 \uc218\uc728, \uc548\uc804\uc131 \ubc0f \uaddc\uc81c \uc218\uc6a9\uc131\uc5d0\uc11c \uc785\uc99d\ub41c \uc774\uc810\uc5d0 \ud798\uc785\uc5b4 7.76%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ucd08\uae30 \ub3c4\uc785 \uae30\uc5c5\ub4e4\uc740 \ub450 \uc790\ub9bf\uc218 \ub9c8\uc9c4 \ud655\ub300\uc640 \ubcf4\uc870 \uc2dc\uc124\ub85c\uc758 \uae30\uc220 \uc774\uc804 \uc8fc\uae30 \ub2e8\ucd95\uc744 \ubcf4\uace0\ud569\ub2c8\ub2e4. \uc0dd\uccb4 \ucd09\ub9e4 \ubc0f \ud6a8\uc18c \uacbd\ub85c(Biocatalytic and Enzymatic Routes)\ub294 \ud2c8\uc0c8\uc2dc\uc7a5\uc774\uc9c0\ub9cc, \ud6a8\uc18c \uacf5\ud559 \ube44\uc6a9\uc774 \uac10\uc18c\ud558\uace0 \uc9c0\uc18d \uac00\ub2a5\uc131 \uc9c0\ud45c\uac00 \uaddc\uc81c \uc758\uc81c\uc5d0 \uc624\ub974\uba74\uc11c \uc2e0\ub8b0\ub97c \uc5bb\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ub300\ub7c9 \uc544\ubbf8\ub178\uc0b0 \uc720\ub3c4\uccb4 \ubc0f \uc77c\ubd80 \ud0a4\ub784 \uc5d0\ud3ed\uc0ac\uc774\ub4dc\ub294 \uc774\ubbf8 \ud6a8\uc18c \uc0dd\uc0b0\uc73c\ub85c \uc804\ud658\ub418\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uaddc\ubaa8\uc758 \uacbd\uc81c\uac00 \uade0\ud615\uc744 \uc774\ub8e8\uba74 \uc774 \ubd80\ubb38\uc758 \uc810\uc720\uc728\uc774 \ubd88\uade0\ud615\uc801\uc73c\ub85c \uc99d\uac00\ud560 \uc218 \uc788\uc74c\uc744 \uc2dc\uc0ac\ud569\ub2c8\ub2e4.<\/p>\n<p>4.4. \ucd5c\uc885 \uc0ac\uc6a9\uc790\ubcc4 \ubd84\uc11d: \ud601\uc2e0 \uae30\uc5c5\uc774 \uc131\uc7a5\uc744 \uac00\uc18d\ud654\ud569\ub2c8\ub2e4.<br \/>\n\uc81c\ub124\ub9ad \uc758\uc57d\ud488 \uc81c\uc870\uc5c5\uccb4(Generic Drug Manufacturers)\ub294 2025\ub144 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5 \uc810\uc720\uc728\uc758 53.10%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc774\ub294 \uae00\ub85c\ubc8c \ud5ec\uc2a4\ucf00\uc5b4\uc5d0\uc11c \ub2e4\uc911 \uc18c\uc2a4 \ubd84\uc790\uc758 \uc5ec\uc804\ud788 \uc9c0\ubc30\uc801\uc778 \uc5ed\ud560\uc744 \ubc18\uc601\ud569\ub2c8\ub2e4. \uadf8\ub7ec\ub098 \ud601\uc2e0 \uc81c\uc57d \ud68c\uc0ac(Innovative Pharma Companies)\ub294 \ud2b9\ud5c8 \ubcf4\ud638 \uc790\uc0b0\uc774 \uac15\ud654\ub428\uc5d0 \ub530\ub77c 7.62%\uc758 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \uc774\ub4e4 \uae30\uc5c5\uc740 \uac1c\ubc1c \uc11c\ube44\uc2a4\uc640 \ubcf4\uc7a5\ub41c \uc0c1\uc5c5\uc801 \ubb3c\ub7c9\uc744 \ubb36\ub294 \ub2e4\uc911 \ud654\ud569\ubb3c, \ub2e4\ub144\uac04 \uacf5\uae09 \uacc4\uc57d\uc744 \uc810\uc810 \ub354 \ub9ce\uc774 \uccb4\uacb0\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc704\ud0c1 \uc5f0\uad6c \ubc0f \uc81c\uc870 \uae30\uad00(CROs\/CDMOs)\uc740 \uc81c\ub124\ub9ad \ubc0f \ud601\uc2e0 \uace0\uac1d \ubaa8\ub450\uc758 \uc0dd\uc0b0 \ub2a5\ub825 \uc555\ub825\uc744 \ud761\uc218\ud558\uba70 \uacf5\uae09\ub9dd\uc758 \uc5f0\uacb0 \uc870\uc9c1 \uc5ed\ud560\uc744 \ud569\ub2c8\ub2e4. \uc2dc\uc7a5 \uc120\ub450 \uae30\uc5c5\ub4e4\uc740 \uc644\uc81c \uc758\uc57d\ud488 \uc81c\uc870\ub85c \uc804\ubc29 \ud1b5\ud569\uc744 \uc2dc\uc791\ud588\uc73c\uba70, \uc774\ub294 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ubcf4\ud558\uace0 \ucd08\uae30 \ub2e8\uacc4 \ud504\ub85c\uc81d\ud2b8 \ud30c\uc774\ud504\ub77c\uc778\uc758 \ubcc0\ub3d9\uc131\uc744 \uc644\ud654\ud558\ub294 \uc804\ub7b5\uc785\ub2c8\ub2e4.<\/p>\n<p># 5. \uc9c0\uc5ed \ubd84\uc11d<\/p>\n<p>*   \ubd81\ubbf8: 2025\ub144 \ub9e4\ucd9c\uc758 41.80%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, 1,600\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\uc758 \uc81c\uc870 \ud22c\uc790 \ubc1c\ud45c\uc640 \uad6d\ub0b4 \uc18c\uc2f1\uc744 \uc7a5\ub824\ud558\ub294 \uc815\ucc45 \ud658\uacbd\uc5d0 \ud798\uc785\uc5b4 \uc131\uc7a5\ud588\uc2b5\ub2c8\ub2e4. FDA PreCheck \ud504\ub85c\uadf8\ub7a8\uacfc \ubd80\uc871 \uc644\ud654 \uacc4\ud68d \ucd08\uc548\uc740 \uc774\ubbf8 \uac80\uc0ac \ub300\uae30 \uc2dc\uac04\uc744 \ub2e8\ucd95\ud558\uace0 \uc788\uc73c\uba70, \uc774\ub294 \uad6d\ub0b4 \uc0dd\uc0b0\uc744 \uc7a5\ub824\ud558\uace0 \uacf5\uae09\ub9dd \ud0c4\ub825\uc131\uc744 \uac15\ud654\ud558\ub294 \ub370 \uae30\uc5ec\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc720\ub7fd: 2025\ub144 \ub9e4\ucd9c\uc758 28.30%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ubc14\uc774\uc624 \uc758\uc57d\ud488 \uc81c\uc870\uc5d0 \ub300\ud55c \uac15\ub825\ud55c \ud22c\uc790\uc640 \ud601\uc2e0\uc801\uc778 \uce58\ub8cc\ubc95 \uac1c\ubc1c\uc5d0 \uc911\uc810\uc744 \ub450\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc720\ub7fd\uc5f0\ud569(EU)\uc740 \uc758\uc57d\ud488 \uc0dd\uc0b0 \uc5ed\ub7c9\uc744 \uac15\ud654\ud558\uace0 \uacf5\uae09\ub9dd \uc758\uc874\ub3c4\ub97c \uc904\uc774\uae30 \uc704\ud55c \ub2e4\uc591\ud55c \uc774\ub2c8\uc154\ud2f0\ube0c\ub97c \ucd94\uc9c4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ub3c5\uc77c, \uc2a4\uc704\uc2a4, \uc544\uc77c\ub79c\ub4dc\ub294 \uace0\ubd80\uac00\uac00\uce58 \uc758\uc57d\ud488 \uc81c\uc870\uc758 \ud5c8\ube0c\ub85c \uc790\ub9ac\ub9e4\uae40\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591: 2025\ub144 \ub9e4\ucd9c\uc758 20.10%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \uc911\uad6d\uacfc \uc778\ub3c4\uac00 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc785\ub2c8\ub2e4. \uc774 \uc9c0\uc5ed\uc740 \uc800\ub834\ud55c \uc81c\uc870 \ube44\uc6a9\uacfc \ub300\uaddc\ubaa8 \uc0dd\uc0b0 \ub2a5\ub825\uc73c\ub85c \uc778\ud574 \uc81c\ub124\ub9ad \uc758\uc57d\ud488 \ubc0f \ubc14\uc774\uc624\uc2dc\ubc00\ub7ec \uc0dd\uc0b0\uc758 \uc8fc\uc694 \uac70\uc810\uc785\ub2c8\ub2e4. \ub610\ud55c, \ud604\uc9c0 \uc2dc\uc7a5\uc758 \uc218\uc694 \uc99d\uac00\uc640 \uc815\ubd80\uc758 \uc81c\uc57d \uc0b0\uc5c5 \uc721\uc131 \uc815\ucc45\uc774 \uc131\uc7a5\uc744 \uacac\uc778\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc77c\ubcf8\uacfc \ud55c\uad6d\uc740 \uace0\ud488\uc9c8 \uc758\uc57d\ud488 \ubc0f \ucca8\ub2e8 \ubc14\uc774\uc624 \uc758\uc57d\ud488 \uc81c\uc870 \ubd84\uc57c\uc5d0\uc11c \uc785\uc9c0\ub97c \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>*   \uae30\ud0c0 \uc9c0\uc5ed(ROW): 2025\ub144 \ub9e4\ucd9c\uc758 9.80%\ub97c \ucc28\uc9c0\ud588\uc73c\uba70, \ub77c\ud2f4 \uc544\uba54\ub9ac\uce74\uc640 \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74 \uc9c0\uc5ed\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc774\ub4e4 \uc9c0\uc5ed\uc740 \uc544\uc9c1 \uc2dc\uc7a5 \uaddc\ubaa8\ub294 \uc791\uc9c0\ub9cc, \uc758\ub8cc \uc811\uadfc\uc131 \uac1c\uc120\uacfc \ud604\uc9c0 \uc0dd\uc0b0 \uc5ed\ub7c9 \uac15\ud654 \ub178\ub825\uc73c\ub85c \uc778\ud574 \uc7a0\uc7ac\uc801\uc778 \uc131\uc7a5 \uac00\ub2a5\uc131\uc744 \ubcf4\uc774\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ud2b9\ud788 \ube0c\ub77c\uc9c8\uacfc \uba55\uc2dc\ucf54\ub294 \uc81c\uc57d \uc81c\uc870 \ubd84\uc57c\uc5d0\uc11c \uc810\uc9c4\uc801\uc778 \ubc1c\uc804\uc744 \uc774\ub8e8\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 6. \uacbd\uc7c1 \ud658\uacbd<\/p>\n<p>\uc81c\uc57d \uc704\ud0c1 \uc81c\uc870 \uc2dc\uc7a5\uc740 \ub9e4\uc6b0 \uc138\ubd84\ud654\ub418\uc5b4 \uc788\uc73c\uba70, \uc218\ub9ce\uc740 \uae00\ub85c\ubc8c \ubc0f \uc9c0\uc5ed \ud50c\ub808\uc774\uc5b4\uac00 \uacbd\uc7c1\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc2dc\uc7a5 \uc120\ub450 \uae30\uc5c5\ub4e4\uc740 \uaddc\ubaa8\uc758 \uacbd\uc81c, \uae30\uc220 \uc804\ubb38\uc131, \uad11\ubc94\uc704\ud55c \uc11c\ube44\uc2a4 \ud3ec\ud2b8\ud3f4\ub9ac\uc624\ub97c \ud1b5\ud574 \uacbd\uc7c1 \uc6b0\uc704\ub97c \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc8fc\uc694 \uacbd\uc7c1 \uc804\ub7b5\uc73c\ub85c\ub294 \uc778\uc218 \ud569\ubcd1(M&#038;A)\uc744 \ud1b5\ud55c \uc5ed\ub7c9 \ud655\uc7a5, \uc2e0\uae30\uc220 \ud22c\uc790(\uc608: \uc5f0\uc18d \uc81c\uc870, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c \uc81c\uc870), \uace0\uac1d\uacfc\uc758 \uc7a5\uae30\uc801\uc778 \ud30c\ud2b8\ub108\uc2ed \uad6c\ucd95 \ub4f1\uc774 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc8fc\uc694 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc740 \ub2e4\uc74c\uacfc \uac19\uc2b5\ub2c8\ub2e4:<\/p>\n<p>*   Lonza Group AG<br \/>\n*   Catalent, Inc.<br \/>\n*   Thermo Fisher Scientific Inc. (Patheon)<br \/>\n*   Siegfried Holding AG<br \/>\n*   Recipharm AB<br \/>\n*   WuXi AppTec<br \/>\n*   Samsung Biologics<br \/>\n*   FUJIFILM Diosynth Biotechnologies<br \/>\n*   Boehringer Ingelheim<br \/>\n*   Piramal Pharma Solutions<\/p>\n<p>\uc774\ub4e4 \uae30\uc5c5\uc740 \uc81c\uc57d \uc0b0\uc5c5\uc758 \ubcc0\ud654\ud558\ub294 \uc694\uad6c\uc0ac\ud56d\uc5d0 \ub9de\ucdb0 \uc11c\ube44\uc2a4 \uc81c\uacf5\uc744 \uc9c0\uc18d\uc801\uc73c\ub85c \ud601\uc2e0\ud558\uace0 \uc788\uc73c\uba70, \ud2b9\ud788 \ubc14\uc774\uc624 \uc758\uc57d\ud488 \ubc0f \ubcf5\uc7a1\ud55c \ubd84\uc790 \uc81c\uc870 \ubd84\uc57c\uc5d0\uc11c \uc804\ubb38\uc131\uc744 \uac15\ud654\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4. \uc18c\uaddc\ubaa8 CROs\/CDMOs\ub294 \ud2b9\uc815 \uae30\uc220\uc774\ub098 \ud2c8\uc0c8 \uc2dc\uc7a5\uc5d0 \uc9d1\uc911\ud558\uc5ec \uacbd\uc7c1\ub825\uc744 \ud655\ubcf4\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p># 7. \uacb0\ub860 \ubc0f \uc804\ub9dd<\/p>\n<p>\uae00\ub85c\ubc8c \uc81c\uc57d \uc704\ud0c1 \uc81c\uc870 \uc2dc\uc7a5\uc740 \uc81c\uc57d \ud68c\uc0ac\ub4e4\uc774 \ud575\uc2ec \uc5ed\ub7c9\uc5d0 \uc9d1\uc911\ud558\uace0 \ube44\uc6a9 \ud6a8\uc728\uc131\uc744 \ucd94\uad6c\ud568\uc5d0 \ub530\ub77c \uc9c0\uc18d\uc801\uc778 \uc131\uc7a5\uc744 \uacbd\ud5d8\ud560 \uac83\uc73c\ub85c \uc608\uc0c1\ub429\ub2c8\ub2e4. \ud2b9\ud788 \ubc14\uc774\uc624 \uc758\uc57d\ud488, \uc138\ud3ec \ubc0f \uc720\uc804\uc790 \uce58\ub8cc\uc81c\uc640 \uac19\uc740 \uace0\uc131\uc7a5 \ubd84\uc57c\ub294 CDMOs\uc5d0\uac8c \uc0c8\ub85c\uc6b4 \uae30\ud68c\ub97c \uc81c\uacf5\ud560 \uac83\uc785\ub2c8\ub2e4. \uacf5\uae09\ub9dd \ud0c4\ub825\uc131, \uad6d\ub0b4 \uc0dd\uc0b0 \uc7a5\ub824 \uc815\ucc45, \uadf8\ub9ac\uace0 \ucca8\ub2e8 \uc81c\uc870 \uae30\uc220\uc758 \ub3c4\uc785\uc740 \uc2dc\uc7a5\uc758 \uc8fc\uc694 \ub3d9\uc778\uc774 \ub420 \uac83\uc785\ub2c8\ub2e4. CDMOs\ub294 \ub2e8\uc21c\ud55c \uc11c\ube44\uc2a4 \uc81c\uacf5\uc790\ub97c \ub118\uc5b4, \uc81c\uc57d \uac1c\ubc1c \ubc0f \uc0dd\uc0b0\uc758 \uc804\ub7b5\uc801 \ud30c\ud2b8\ub108\ub85c\uc11c \uadf8 \uc911\uc694\uc131\uc774 \ub354\uc6b1 \ucee4\uc9c8 \uac83\uc785\ub2c8\ub2e4. \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc740 \ubcc0\ud654\ud558\ub294 \uaddc\uc81c \ud658\uacbd\uacfc \uae30\uc220 \ubc1c\uc804\uc5d0 \uc2e0\uc18d\ud558\uac8c \ub300\uc751\ud558\uba70, \uace0\uac1d\uc758 \ubcf5\uc7a1\ud55c \uc694\uad6c\uc0ac\ud56d\uc744 \ucda9\uc871\uc2dc\ud0a4\uae30 \uc704\ud55c \uc5ed\ub7c9 \uac15\ud654\uc5d0 \uc9c0\uc18d\uc801\uc73c\ub85c \ud22c\uc790\ud574\uc57c \ud560 \uac83\uc785\ub2c8\ub2e4.<\/p>\n<p>\ubcf8 \ubcf4\uace0\uc11c\ub294 \uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc5d0 \ub300\ud55c \ud3ec\uad04\uc801\uc778 \ubd84\uc11d\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4. \uc758\uc57d\ud488 \uc911\uac04\uccb4\ub294 \uc6d0\ub8cc\uc758\uc57d\ud488(API) \uc0dd\uc0b0\uc744 \uc704\ud55c \uc6d0\ub8cc\ub85c \uc0ac\uc6a9\ub418\uac70\ub098, API\uac00 \ub418\uae30 \uc804\uc5d0 \ucd94\uac00\uc801\uc778 \ubd84\uc790 \ubcc0\ud654 \ub610\ub294 \uac00\uacf5\uc744 \uac70\uccd0\uc57c \ud558\ub294 API \ud569\uc131 \uacfc\uc815\uc5d0\uc11c \uc0dd\uc131\ub418\ub294 \ubb3c\uc9c8\uc744 \uc758\ubbf8\ud569\ub2c8\ub2e4. \ubcf8 \ubcf4\uace0\uc11c\ub294 \uc2dc\uc7a5 \uc815\uc758, \uc5f0\uad6c \ubc29\ubc95\ub860, \ud575\uc2ec \uc694\uc57d, \uc2dc\uc7a5 \ud658\uacbd \ubd84\uc11d, \uc2dc\uc7a5 \uaddc\ubaa8 \ubc0f \uc131\uc7a5 \uc608\uce21, \uacbd\uc7c1 \ud658\uacbd, \uadf8\ub9ac\uace0 \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd\uc744 \ud3ec\ud568\ud55c \ud3ec\uad04\uc801\uc778 \ub0b4\uc6a9\uc744 \ub2e4\ub8e8\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\uc758\uc57d\ud488 \uc911\uac04\uccb4 \uc2dc\uc7a5\uc740 2025\ub144 \ubc0f 2026\ub144\uc5d0 486.5\uc5b5 \ub2ec\ub7ec \uaddc\ubaa8\ub85c \ucd94\uc815\ub418\uba70, 2026\ub144\ubd80\ud130 2031\ub144\uae4c\uc9c0 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960(CAGR) 7.05%\ub97c \uae30\ub85d\ud558\uba70 2031\ub144\uc5d0\ub294 683.7\uc5b5 \ub2ec\ub7ec\uc5d0 \uc774\ub97c \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc758 \uc8fc\uc694 \uc131\uc7a5 \ub3d9\ub825\uc73c\ub85c\ub294 \uc544\uc6c3\uc18c\uc2f1 \uc81c\uc870\ub85c\uc758 \uc804\ud658 \uac00\uc18d\ud654, \uc18c\ubd84\uc790 \ud56d\uc554\uc81c API \uc218\uc694 \uc99d\uac00, \ubbf8\uad6d \ubc0f \uc720\ub7fd\uc758 \ub9ac\uc1fc\uc5b4\ub9c1(re-shoring) \uc778\uc13c\ud2f0\ube0c, \uc5f0\uc18d \ud750\ub984 \ud654\ud559(continuous-flow chemistry)\uc5d0 \ub300\ud55c \ud22c\uc790 \ud655\ub300, \ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \ubc0f \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc758\uc57d\ud488 \ud30c\uc774\ud504\ub77c\uc778 \ud655\uc7a5, \uadf8\ub9ac\uace0 AI \uae30\ubc18 \uacbd\ub85c \ud0d0\uc0c9 \ubc0f \ud569\uc131 \ucd5c\uc801\ud654 \uae30\uc220 \ubc1c\uc804 \ub4f1\uc774 \ubd80\uac01\ub418\uace0 \uc788\uc2b5\ub2c8\ub2e4. \ubc18\uba74, \uc2dc\uc7a5 \uc131\uc7a5\uc744 \uc800\ud574\ud558\ub294 \uc694\uc778\uc73c\ub85c\ub294 \uc8fc\uc694 \uc6d0\uc790\uc7ac(\uc6a9\ub9e4, \uc2dc\uc57d) \uac00\uaca9\uc758 \ubcc0\ub3d9\uc131, \uc5c4\uaca9\ud55c \ud658\uacbd \uc601\ud5a5 \uaddc\uc81c \uc900\uc218 \ube44\uc6a9, \uc774\uc911 \uc6a9\ub3c4 \uc804\uad6c\uccb4\uc5d0 \ub300\ud55c \uc9c0\uc815\ud559\uc801 \uc218\ucd9c \ud1b5\uc81c, \uadf8\ub9ac\uace0 \uace0\ud6a8\ub2a5 \uc911\uac04\uccb4 \uc0dd\uc0b0\uc744 \uc704\ud55c CDMO(\uc704\ud0c1\uac1c\ubc1c\uc0dd\uc0b0) \uc5ed\ub7c9 \ubcd1\ubaa9 \ud604\uc0c1 \ub4f1\uc774 \uc8fc\uc694\ud558\uac8c \uc791\uc6a9\ud558\uace0 \uc788\uc2b5\ub2c8\ub2e4.<\/p>\n<p>\ubcf4\uace0\uc11c\ub294 \uac00\uce58\/\uacf5\uae09\ub9dd \ubd84\uc11d, \uaddc\uc81c \ud658\uacbd, \uae30\uc220\uc801 \uc804\ub9dd, \uadf8\ub9ac\uace0 \ud3ec\ud130\uc758 5\uac00\uc9c0 \uacbd\uc7c1 \uc694\uc778 \ubd84\uc11d\uc744 \ud1b5\ud574 \uc2dc\uc7a5\uc758 \uad6c\uc870\uc640 \uc5ed\ud559 \uad00\uacc4\uc5d0 \ub300\ud55c \uc2ec\uce35\uc801\uc778 \uc774\ud574\ub97c \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n<p>\uc2dc\uc7a5\uc740 \uc81c\ud488 \uc720\ud615(\ubc8c\ud06c \uc758\uc57d\ud488 \uc911\uac04\uccb4, \ub9de\ucda4\ud615 \ubc0f \uacc4\uc57d \uc911\uac04\uccb4, \ud3a9\ud0c0\uc774\ub4dc \ubc0f \uc62c\ub9ac\uace0\ub274\ud074\ub808\uc624\ud0c0\uc774\ub4dc \uc911\uac04\uccb4, \ud0a4\ub784 \ubc0f \uace0\ud6a8\ub2a5 \uc911\uac04\uccb4), \uce58\ub8cc \uc751\uc6a9 \ubd84\uc57c(\uc885\uc591\ud559, \uc2ec\ud608\uad00, \uac10\uc5fc\uc131 \uc9c8\ud658, \uc911\ucd94\uc2e0\uacbd\uacc4, \ub300\uc0ac\uc131 \uc9c8\ud658 \ubc0f \uae30\ud0c0), \ud569\uc131 \uacf5\uc815(\uc804\ud1b5 \ubc30\uce58 \ud654\ud559, \uc5f0\uc18d \ud750\ub984 \ud654\ud559, \uc0dd\uccb4 \ucd09\ub9e4 \ubc0f \ud6a8\uc18c \uacbd\ub85c), \ucd5c\uc885 \uc0ac\uc6a9\uc790(\uc81c\ub124\ub9ad \uc758\uc57d\ud488 \uc81c\uc870\uc5c5\uccb4, \ud601\uc2e0 \uc81c\uc57d \ud68c\uc0ac, CRO\/CDMO) \ubc0f \uc9c0\uc5ed(\ubd81\ubbf8, \uc720\ub7fd, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591, \ub0a8\ubbf8, \uc911\ub3d9 \ubc0f \uc544\ud504\ub9ac\uce74)\ubcc4\ub85c \uc138\ubd84\ud654\ub418\uc5b4 \ubd84\uc11d\ub429\ub2c8\ub2e4. \ud2b9\ud788 \uc9c0\uc5ed\ubcc4 \ubd84\uc11d\uc5d0\uc11c\ub294 2025\ub144 \uae30\uc900 \ubd81\ubbf8\uac00 \uac00\uc7a5 \ud070 \uc2dc\uc7a5 \uc810\uc720\uc728\uc744 \ud655\ubcf4\ud588\uc73c\uba70, \uc544\uc2dc\uc544 \ud0dc\ud3c9\uc591 \uc9c0\uc5ed\uc740 \uc608\uce21 \uae30\uac04(2026-2031\ub144) \ub3d9\uc548 \uac00\uc7a5 \ub192\uc740 \uc5f0\ud3c9\uade0 \uc131\uc7a5\ub960\uc744 \uae30\ub85d\ud560 \uac83\uc73c\ub85c \uc804\ub9dd\ub429\ub2c8\ub2e4.<\/p>\n<p>\uacbd\uc7c1 \ud658\uacbd \ubd84\uc11d\uc5d0\ub294 \uc2dc\uc7a5 \uc9d1\uc911\ub3c4, \uc2dc\uc7a5 \uc810\uc720\uc728 \ubd84\uc11d, \uadf8\ub9ac\uace0 Lonza Group AG, WuXi AppTec Co., Ltd., Thermo Fisher Scientific Inc., Cambrex Corporation, Siegfried Holding AG, Divi\u2019s Laboratories Ltd., Sanofi S.A., Merck KGaA, BASF SE \ub4f1 \uc8fc\uc694 \uae30\uc5c5\ub4e4\uc758 \uc0c1\uc138 \ud504\ub85c\ud544\uc774 \ud3ec\ud568\ub429\ub2c8\ub2e4. \uc774\uc640 \ub354\ubd88\uc5b4, \uc2dc\uc7a5 \uae30\ud68c \ubc0f \ubbf8\ub798 \uc804\ub9dd, \ubbf8\uac1c\ucc99 \ubd84\uc57c(White-space) \ubc0f \ucda9\uc871\ub418\uc9c0 \uc54a\uc740 \uc694\uad6c(Unmet-Need)\uc5d0 \ub300\ud55c \ud3c9\uac00\uac00 \uc81c\uc2dc\ub418\uc5b4 \uc2dc\uc7a5 \ucc38\uc5ec\uc790\ub4e4\uc5d0\uac8c \uadc0\uc911\ud55c \uc804\ub7b5\uc801 \ud1b5\ucc30\ub825\uc744 \uc81c\uacf5\ud569\ub2c8\ub2e4.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-60962","post","type-post","status-publish","format-standard","hentry","category-market-reports"],"_links":{"self":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/60962"}],"collection":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/comments?post=60962"}],"version-history":[{"count":0,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/posts\/60962\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/media?parent=60962"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/categories?post=60962"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.globalresearch.co.kr\/insight\/wp-json\/wp\/v2\/tags?post=60962"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}